Document Detail


Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration.
MedLine Citation:
PMID:  11796829     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute experimental iron loading causes iron to accumulate in the renal tissue. The accumulation of iron may play a role in enhancing oxidant-induced tubular injury by producing increased amounts of reactive oxygen species. From findings in cells from heme oxygenase-1 (HO-1)-deficient mice, HO-1 is postulated to prevent abnormal intracellular iron accumulation. Recently, it has been reported that HO-1 is induced in the renal tubular epithelial cells, in which iron is deposited after iron loading, and that this HO-1 induction may be involved in ameliorating iron-induced renal toxicity. We previously showed that chronic administration of angiotensin II to rats induces HO-1 expression in the tubular epithelial cells. These observations led us to investigate whether there is a link between iron deposition and HO-1 induction in renal tubular cells in rats undergoing angiotensin II infusion. In the present study, rats were given angiotensin II for continuously 7 days. Prussian blue staining revealed the distinct deposits of iron in the proximal tubular epithelial cells after angiotensin II administration. Electron microscopy demonstrated that iron particles were present in the lysosomes of these cells. Histologic and immunohistochemical analyses showed that stainable iron and immunoreactive ferritin and HO-1 were colocalized in the tubular epithelial cells. Treatment of angiotensin II-infused rats with an iron chelator, deferoxamine, blocked the abnormal iron deposition in kidneys and also the induced expression of HO-1 and ferritin expression. Furthermore, deferoxamine treatment suppressed the angiotensin II-induced increase in the urinary excretion of protein and N-acetyl-beta-D-glucosaminidase, a marker of tubular injury; however, deferoxamine did not affect the angiotensin II-induced decrease in glomerular filtration rate. These results suggest that angiotensin II causes renal injury, in part, by inducing the deposition of iron in the kidney.
Authors:
Nobukazu Ishizaka; Toru Aizawa; Ieharu Yamazaki; Shin-ichi Usui; Ichiro Mori; Kiyoshi Kurokawa; Shiow-Shih Tang; Julie R Ingelfinger; Minoru Ohno; Ryozo Nagai
Related Documents :
9125179 - Hemoglobin is utilized by candida albicans in the hyphal form but not yeast form.
9108449 - Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
6090189 - Transferrin receptors and iron utilization in dmso-inducible and -uninducible friend er...
15142409 - Comparison of transfection agents in forming complexes with ferumoxides, cell labeling ...
507519 - Lysosomal enzyme activities in pulmonary macrophages from rabbits breathing iron oxide.
10861799 - Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor m...
3599129 - Glycocalyceal bodies--a marker for different epithelial cell types in human airways.
17832539 - Energy recovery from saline water by means of electrochemical cells.
19070999 - Gravitaxis of bursaria truncatella: electrophysiological and behavioural analyses of a ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Laboratory investigation; a journal of technical methods and pathology     Volume:  82     ISSN:  0023-6837     ISO Abbreviation:  Lab. Invest.     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-01-17     Completed Date:  2002-02-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376617     Medline TA:  Lab Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  87-96     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. nobuishizka-tky@umin.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylglucosaminidase / urine
Angiotensin II / administration & dosage,  pharmacokinetics,  pharmacology*
Animals
Blood Pressure / drug effects
Creatinine / urine
Ferritins / biosynthesis
Heart Rate / drug effects
Heme Oxygenase (Decyclizing) / deficiency
Heme Oxygenase-1
Hemodynamics / drug effects
Iron / blood,  metabolism*
Kidney / drug effects,  metabolism*,  pathology
Kidney Cortex / drug effects,  metabolism
Kidney Medulla / drug effects,  metabolism
Kidney Tubules / drug effects,  metabolism
Membrane Proteins
Mice
Mice, Knockout
Proteinuria
Rats
Urothelium / drug effects,  metabolism
Chemical
Reg. No./Substance:
0/Membrane Proteins; 11128-99-7/Angiotensin II; 60-27-5/Creatinine; 7439-89-6/Iron; 9007-73-2/Ferritins; EC 1.14.99.3/Heme Oxygenase (Decyclizing); EC 1.14.99.3/Heme Oxygenase-1; EC 1.14.99.3/Hmox1 protein, mouse; EC 3.2.1.52/Acetylglucosaminidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1...
Next Document:  Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadi...